BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 17385343)

  • 21. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
    Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
    Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Human transmissible dementia: prion diseases?].
    Dreux C; Laplanche JL; Chatelain J
    Bull Acad Natl Med; 1992 Nov; 176(8):1279-88; discussion 1289-91. PubMed ID: 1300226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular genetics of familial and sporadic forms of human prion diseases].
    Laplanche JL; Launay JM; Dreux C
    Ann Pharm Fr; 1995; 53(5):193-200. PubMed ID: 7503507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the 37 kDa laminin receptor precursor in the life cycle of prions.
    Rieger R; Lasmézas CI; Weiss S
    Transfus Clin Biol; 1999 Feb; 6(1):7-16. PubMed ID: 10188208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Righetti PG; Ferrari S; Terrin L; Farinazzo A; Cardone F; Pocchiari M; Rizzuto N; Monaco S
    Electrophoresis; 2002 Jan; 23(2):347-55. PubMed ID: 11840543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion diseases and emerging prion diseases.
    Yokoyama T; Mohri S
    Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Unconventional transmissible agents and prion protein: is something still missing?].
    Laplanche JL
    Ann Biol Clin (Paris); 1997; 55(5):395-407. PubMed ID: 9347006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT; Lazo ND
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
    Manuelidis L
    J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prion protein: structure, functions and polymorphisms associated with human spongiform encephalopathies].
    Laplanche JL; Beaudry P; Ripoll L; Launay JM
    Pathol Biol (Paris); 1995 Feb; 43(2):104-13. PubMed ID: 7777379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
    Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.